Fractyl Health (GUTS) EV/FCF: History & Chart

Fractyl Health, Inc.(GUTS)

Biotechnology · Burlington, MA

$4.61+0.05 (+1.10%)

Delayed quote: Oct 6, 2026, 3:10 PM EDT

About Fractyl Health, Inc.

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Burlington, MA

100 employees

fractyl.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Harith Rajagopalan

View full financials

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Fractyl Health, Inc. (GUTS)	$60.95M	N/A	N/A	N/A	N/A
Kalaris Therapeutics Inc (KLRS)vs ›	$61.38M	N/A	N/A	N/A	N/A
PDS Biotechnology Corporation (PDSB)vs ›	$60.40M	N/A	N/A	N/A	N/A
Oncolytics Biotech Inc. (ONCY)vs ›	$60.22M	N/A	N/A	N/A	N/A
RenovoRx, Inc. (RNXT)vs ›	$63.07M	N/A	N/A	N/A	N/A
Heron Therapeutics, Inc. (HRTX)vs ›	$62.29M	N/A	1.41x	1.41x	1.41x
Xilio Therapeutics, Inc. (XLO)vs ›	$60.49M	N/A	N/A	N/A	N/A
InterCure Ltd. (INCR)vs ›	$63.02M	14.40x	12.61x	12.61x	118.68x
Adicet Bio, Inc. (ACET)vs ›	$59.64M	N/A	108.20x	108.20x	108.20x
Pliant Therapeutics, Inc. (PLRX)vs ›	$63.16M	N/A	41.03x	41.03x	41.03x

NAME

MARKET CAP

EV/FCF RATIO

TTM

Fractyl Health, Inc. (GUTS)

$60.95M

N/A

Kalaris Therapeutics Inc (KLRS)vs ›

$61.38M

N/A

PDS Biotechnology Corporation (PDSB)vs ›

$60.40M